NEUROPHARMACOLOGICAL AND HEMODYNAMIC DIVERGENCE OF FIRST- VERSUS SECOND-GENERATION H1-RECEPTOR ANTAGONISTS: CLINICAL IMPLICATIONS IN ALLERGIC DERMATOSES. World Bulletin of Public Health, v. 56, p. 89–92, 26 Mar.2026.